Moderna, Inc. (MRNA) 今日盘中大涨5.26%，引起了市场的广泛关注。
消息面上，Moderna宣布与流行病防范创新联盟（CEPI）扩大合作，CEPI承诺提供高达5000万美元资金，用于支持其针对本迪布焦埃博拉病毒候选疫苗的临床前开发及一期临床试验。该笔资金将支持临床评估期间的并行制造活动，并为后续大规模二/三期试验奠定基础。
此外，公司此前披露已做好充分准备，预计在八月中旬前完成新冠疫苗组分的生产供应部署，多项管线推进提振市场信心。Moderna是mRNA医学领域的领导者，其平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗开发成为可能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.